Alternative Brands for Rosuvastatin 10 mg

Important Note on the Acidity

1. Add a PPI or antacid - Pantoprazole / Omeprazole 20 mg OD before breakfast alongside the statin.
2. Advise taking Rosuvastatin with food - it can reduce GI upset.
3. Switch the timing - evening dose with dinner may help.
4. Dose reduction - if clinically appropriate, drop to Rosuvastatin 5 mg and reassess.
5. Switch the drug class - if GI intolerance persists, consider Atorvastatin (which some patients tolerate better GI-wise) - brands: Atorva, Lipitor, Tonact.

Clinical Scenario

• Raised OT (AST) / PT (ALT) - hepatocellular injury pattern
• Prolonged Prothrombin Time (PT/INR) - synthetic dysfunction
• Anemia
• No ascites (compensated / early decompensation)

Step 1 - Severity Assessment First

DF = 4.6 × (PT patient - PT control) + serum bilirubin (mg/dL)

Step 2 - Cornerstone Treatment

A. Alcohol Abstinence (Most Important)

• Strict complete abstinence - this alone can reverse fatty liver and improve hepatitis
• Refer to de-addiction / alcohol rehabilitation program
• Naltrexone 50 mg/day - most evidence-based pharmacotherapy for alcohol use disorder (avoid if severe hepatitis - monitor LFTs)
• Alternatives: Acamprosate, Disulfiram (use cautiously in liver disease)

B. Nutritional Supplementation (Critical)

Always give Thiamine BEFORE glucose to avoid precipitating Wernicke's.

C. Anemia Management

D. Coagulopathy (Prolonged PT/INR)

• Vitamin K 10 mg IV/IM x 3 days - if PT doesn't correct, confirms hepatocellular synthetic failure (not just malabsorption)
• Do NOT give oral Vitamin K - poor gut absorption in jaundice
• FFP only if active bleeding or before invasive procedures
• Avoid NSAIDs, aspirin

E. Severe Alcoholic Hepatitis (if DF > 32 or GAHS > 9)

• Prednisolone 40 mg/day orally x 4 weeks, then taper over 2-4 weeks
  • Preferred over prednisone (liver converts prednisone to prednisolone)
  • Shown to reduce 28-day mortality
  • After 7 days: calculate Lille Score - if > 0.45, patient is not responding, discontinue steroids
• Pentoxifylline (400 mg TID x 4 weeks) - previously used, but current evidence (STOPAH trial) shows no survival benefit; may still be used if steroids contraindicated

F. Hepatoprotective Agents

• Silymarin (Milk Thistle) - 140 mg TID, widely used in India, some evidence for liver protection
• UDCA (Ursodeoxycholic acid) - 10-15 mg/kg/day - helps in cholestasis
• SAMe (S-Adenosyl Methionine) - adjunct hepatoprotection

G. Monitor and Prevent Complications

• Spontaneous Bacterial Peritonitis - if ascites develops
• Hepatic encephalopathy - restrict protein if encephalopathy develops, give Lactulose
• Varices - Upper GI endoscopy for screening; Propranolol for prophylaxis
• Renal function - AKI can develop rapidly (hepatorenal syndrome)
• Blood glucose - hypoglycemia is common

H. Liver Transplantation

• Refer to hepatologist/transplant center if ESLD (end-stage liver disease)
• Traditionally requires 6 months abstinence
• Recent data supports early transplant in highly selected severe cases

Summary Drug Chart

Sources: The Washington Manual of Medical Therapeutics, p. 724-725 | Sleisenger & Fordtran's Gastrointestinal and Liver Disease | ACG Clinical Guidelines 2024

Lab Report Summary - Mrs. Rekha, 25F, 11 Weeks Pregnant

Interpretation

TSH 2.35 at 11 Weeks - Clinical Significance

• At 11 weeks, hCG levels are near peak, which normally suppresses TSH - TSH should ideally be on the lower side in the first trimester
• A TSH approaching 2.5 at this stage suggests the thyroid may not be compensating adequately for pregnancy demands
• The elevated Total T3 (255, normal up to 200) is expected in pregnancy due to rising TBG (estrogen-driven), so total T3 elevation alone is not alarming
• Total T4 at 12.4 is within normal but again near upper limit (also due to TBG rise)

ANC Management Plan

1. Immediate Investigations

2. Decision to Start Levothyroxine

• Levothyroxine 25-50 mcg/day in euthyroid women with rising TSH
• Target: TSH in the lower half of trimester-specific range (0.5-2.5 mIU/L)
• Only T4 (Levothyroxine) should be used in pregnancy - never T3 alone, never desiccated thyroid
• Take on empty stomach, 30-60 min before food

3. Monitoring Schedule

4. Routine ANC at 11 Weeks (India MoHFW Protocol)

• Folic acid 5 mg/day (continue till 12 weeks minimum; some guidelines till delivery)
• Iron + Folic acid (IFA tablet) - 1 OD after meals
• Calcium 1-1.5 g/day from 2nd trimester
• Iodized salt - ensure use (WHO recommends 250 µg iodine/day in pregnancy)
• Aspirin 75-150 mg/day - if risk factors for pre-eclampsia (start before 16 weeks)

5. Counselling Points

• Importance of thyroid hormone for fetal brain development - must not skip thyroid follow-up
• Maintain iodized salt use
• Levothyroxine should be taken separately from iron / calcium tablets (minimum 4-hour gap, as they reduce absorption)
• Regular ANC follow-up every 4 weeks
• Return immediately for nausea, vomiting, palpitations, or excessive weight gain

In short: TSH 2.35 at 11 weeks is borderline for first trimester. Check anti-TPO antibodies urgently. If positive, start Levothyroxine 25-50 mcg/day and monitor TSH every 4 weeks. Ensure routine ANC workup, NT scan, and nutritional supplementation are completed.

Sources: Creasy & Resnik's Maternal-Fetal Medicine, p. 1608-1614 | Harrison's Principles of Internal Medicine 22E, p. 2976-2978 | ATA Guidelines 2017 (Thyroid Disease in Pregnancy)